Amneal Pharmaceuticals
AMRX
AMRX
128 hedge funds and large institutions have $302M invested in Amneal Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 48 increasing their positions, 39 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
0.33% less ownership
Funds ownership: 63.88% → 63.56% (-0.33%)
11% less funds holding
Funds holding: 144 → 128 (-16)
59% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 27
Holders
128
Holding in Top 10
1
Calls
$331K
Puts
$118K
Top Buyers
| 1 | +$8.06M | |
| 2 | +$5.11M | |
| 3 | +$2.41M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$2.17M |
| 5 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
+$1.25M |
Top Sellers
| 1 | -$6.4M | |
| 2 | -$6.05M | |
| 3 | -$3.98M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$2.65M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$445K |